Clinical Trial Update: Long Term Arrhythmia Risk and Cardiovascular Events in Hematopoietic Stem Cell Transplant

View source ↗

Summary

A clinical trial update evaluating long-term risk of arrhythmias, including atrial fibrillation and atrial flutter, and other cardiovascular events after hemato…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Hematopoietic Stem Cell Transplant, Atrial Fibrillation | Status: COMPLETED